GlobeNewswire

AGC Biologics partners with Child’s Cure Genetic Research to pursue mRNA-based therapeutic for severe epileptic disorder
10/11/2026
Demonstrates new evolution in mRNA to address rare conditions CDMO’s work with parent-led, patient-focused foundation will investigate a development pathway to combat CDKL5 Deficiency Disorder AGC Biologics is well [...]
Nelipak Healthcare Packaging Acquires Technipaq, Inc.
10/11/2026
Strengthens sterile-barrier flexible healthcare packaging presence in the Americas region CRANSTON, R.I., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Nelipak ® Corporation (“Nelipak ® ”) , a leading global provider of healthcare [...]
JenaValve Presents Late-Breaking JENA-VAD Data at TCT 2026, Demonstrating High Technical Success and 30 Day Safety of the Trilogy System in LVAD Patients Under IDE
10/11/2026
- Data reflects outcomes from 50 patients with Left Ventricular Assist Devices (LVADs) and Clinically Significant Aortic Regurgitation (AR) treated with the Trilogy System - Demonstrated 96% technical success with no [...]
Metabolon Expands Verus™ Metabolomics Profiling Kit Availability to Europe and Adds New Rodent Sample Types
10/11/2026
Now available to order in Europe, the Metabolon Verus™ Metabolomics Profiling Kit delivers results in just five days, with human and rodent blood sample types and proven reproducibility across eight independent [...]
HealthEx Partners with Oscar Insurance to Bring Members’ Medical Records Into the Oscar App
10/11/2026
Oscar members can see their full health history in one place and get more personalized answers from Oscar’s AI agent, as Oscar Insurance becomes one of the first health plans to connect records through HealthEx SAN [...]
Daré Bioscience to Host Third Quarter 2026 Financial Results and Company Update Conference Call and Webcast on November 16, 2026
10/11/2026
SAN DIEGO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world [...]
Alpha Pro Tech, Ltd. Announces Third Quarter 2026 Financial Results
10/11/2026
Third Quarter Net Sales Increased by 12.3% to $16.6 Million, from $14.8 Million for the Third Quarter of 2025 Third Quarter Net Income Increased by 97.2% to $1.9 Million from $1.0 Million in the Prior Year Period Net [...]
Nu-Tek BioSciences passe avec succès l’audit de certification ISO 9001, renforçant ainsi son engagement en faveur de la qualité des matières premières
10/11/2026
Le maintien de la certification ISO 9001 confirme l’importance que Nu-Tek accorde à la gestion de la qualité, à la constance de fabrication et aux priorités de ses clients du secteur biopharmaceutique en matière d’ [...]
Nu-Tek BioSciences Successfully Completes ISO 9001 Certification Review, Reinforcing Commitment to Raw Material Quality
10/11/2026
Continuous ISO 9001 certification reinforces Nu-Tek’s focus on quality management, manufacturing consistency, and the supplier assurance priorities of biopharmaceutical customers MINNETONKA, Minn., Nov. 10, 2026 (GLOBE [...]
Franciscan Health and Ossium Health Perform World's First Organ Donor Bone Marrow Transplant for Non-Malignant Disease
10/11/2026
Patient with severe aplastic anemia successfully transplanted, expanding access to a stem cell source long considered optimal for non-malignant conditions INDIANAPOLIS, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Franciscan [...]
Rakovina Therapeutics Secures Exclusive Worldwide Licence to Artemis.AI™ Platform for DNA-Damage Response Oncology Drug Discovery
10/11/2026
Perpetual, royalty-free, exclusive licence for DDR oncology including all future platform improvements, in exchange for C$1.0 million in Rakovina shares VANCOUVER, British Columbia, Nov. 10, 2026 (GLOBE NEWSWIRE) -- [...]
TETmedical Appoints Dr. Hooman Kamel and Dr. Evan Gerber as Medical Advisors
10/11/2026
Leading Vascular Neurologist and Emergency Physician Bring Front-Line Stroke Expertise as TETmedical Advances NSE-FAST® Through Its Pivotal Study FAIR HAVEN, N.J. and ITHACA, N.Y., Nov. 10, 2026 (GLOBE NEWSWIRE) -- [...]
Valneva annonce un taux de séroréponse de 94% cinq ans après une dose unique du vaccin contre le chikungunya IXCHIQ®
10/11/2026
94% des participants ont maintenu une séroréponse cinq ans après une dose unique du vaccin La persistance des anticorps chez les adultes âgés de 65 ans et plus est comparable à celle des jeunes adultes Ces données [...]
Valneva Reports Sustained 94% Seroresponse Five Years After a Single Dose of Chikungunya Vaccine IXCHIQ®
10/11/2026
94% of participants maintained seroresponse five years after a single vaccination Comparable antibody persistence observed in older (65+) and younger adults Data further reinforce IXCHIQ ® 's differentiated profile with [...]
Roche presents new data across pharmaceuticals and diagnostics from its growing Alzheimer’s disease portfolio at CTAD 2026
10/11/2026
Updated Phase Ib/IIa Brainshuttle™ AD study data for trontinemab demonstrating rapid amyloid removal dynamics and changes in key biomarkers Phase III PrevenTRON study design specifics for trontinemab in preclinical [...]
Trogenix appoints industry veterans John Young as Chair and Josh Murray as Non-Executive Director to support global strategy, commercial foundation and patient access
10/11/2026
John brings more than 35 years of operational and commercial leadership with extensive experience in bringing medicines to market at global scale Josh brings deep capital markets and strategic experience to support the [...]
TME Pharma fournit davantage de détails sur l'accord de négociation exclusif conclu avec TMS Co., Ltd. concernant le NOX-A12
10/11/2026
TME Pharma fournit davantage de détails sur l'accord de négociation exclusif conclu avec TMS Co., Ltd. concernant le NOX-A12 Berlin, Allemagne, le 10 novembre 2026, 8h30 CET – TME Pharma N.V. (Euronext Growth Paris: [...]
TME Pharma provides further details on the exclusive negotiation agreement with TMS Co., Ltd. for NOX-A12
10/11/2026
TME Pharma provides further details on the exclusive negotiation agreement with TMS Co., Ltd. for NOX-A12 Berlin, Germany, November 10, 2026, 8.30 am CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a biotech- [...]
TECregen Strengthens Management Team and Board to Advance Thymus Regeneration and Lead Program TEC001
10/11/2026
Elisabeth Svanberg, MD, PhD, appointed Chief Medical Officer, adding extensive global clinical-development and regulatory expertise Thomas Hanke, PhD, joins the Board, bringing more than 30 years of immunology, drug- [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum